Kymera Therapeutics
KYMR
KYMR
115 hedge funds and large institutions have $2.04B invested in Kymera Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
8.91% more ownership
Funds ownership: 58.95% → 67.86% (+8.9%)
5% more funds holding
Funds holding: 110 → 115 (+5)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
115
Holding in Top 10
4
Calls
$13.1M
Puts
$549K
Top Buyers
| 1 | +$96.3M | |
| 2 | +$81.5M | |
| 3 | +$50.4M | |
| 4 |
BlackRock
New York
|
+$34.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$32.4M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$25.2M | |
| 3 | -$23.3M | |
| 4 |
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
|
-$13.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.81M |